Skip to content

Effect of Tobacco Heating System (THS) on Closed Lower Limb Fracture Healing

Evaluation of Tobacco Heating System (THS) Compared to Conventional Cigarette Smoking During the Closed Lower Limb (Tibia and Femur) Fracture Healing in Orthopedic Smokers' Patients

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05859451
Enrollment
150
Registered
2023-05-16
Start date
2023-06-02
Completion date
2026-04-17
Last updated
2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking, Tibia Fracture

Keywords

Bone healing, Tobacco heating system, Smoking cessation

Brief summary

The goal of this clinical trial is to investigate the role of switching from cigarette smoking (CS) to tobacco heat system (THS) on the clinical outcome of closed lower limb (tibia and femur) fractures from smokers' orthopedic patients. Validated and standardized assays, medical state and self-reported outcomes will be evaluated in orthopedic patients' smokers or switch from CS to using THS throughout six months compare to ex-smokers (control).

Interventions

DEVICETobacco Heating System (THS)

Participant who are not willing to quit cigarette smoking during the study duration will switch from cigarettes to using THS

Participant who are willing to quit cigarette smoking and will not use any electronic nicotine delivery system during the study duration

Sponsors

Philip Morris Products S.A.
CollaboratorINDUSTRY
University Hospital Tuebingen
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Closed tibia or femur fracture (according to AO/OTA: 41A2-41C3, 42A-C, 43A-C, 32A-C, 33A2-3, 33B-C) which is surgically treated within 14 days after the trauma at the BG trauma clinic Tübingen. Additional inclusion criteria for the smoking and THS groups: * Smokers with 10-20 packyears smoking history. * Smoking history \>10 years. * Decision not to participate in the free smoking cessation seminars.

Exclusion criteria

* Legal guardian or loss of capacity to consent. * Refusal to participate in the study. * Open fractures or concomitant injuries or complications requiring surgery existing at the time of surgical indication. * Initial surgical treatment of the fracture has occurred ex domo. * No initial surgical treatment within 14 days of sustained trauma. * Using nicotine delivery electronic devices. * Pre-existing autoimmune, immunological, bone or malignant diseases. * Pregnant, breastfeeding and women of childbearing age with existing desire to have children. * History of alcohol abuse or drug abuse. * Taking antioxidants approval by the German Federal Institute for Drugs and Medical Devices (BfArM). * Taking drugs with known effect on bone metabolism (according to Institute for medical and pharmaceutical examination issues (IMPP): allosteric CaSR modulators, bisphosphonates, calcium release inhibitors, alkaline earth ions, RANKL inhibitors, calcitriol, colecalciferol).

Design outcomes

Primary

MeasureTime frameDescription
Concentration of Procollagen Type 1 N-Terminal Propeptide (CICP)6 months after tibia fracture surgeryMarker collagen formation - bone formation

Secondary

MeasureTime frameDescription
Concentration of Osteopontin6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)Extracellular structural protein and an organic component of bone - favors osteoclast adherence
Concentration of N-terminal telopeptide (NTx)6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)Marker collagen degradation - bone resorption
Concentration of Interleukin 1 beta (IL-1β)6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of Interleukin 6 (IL-6)6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of Interferon gamma (IFN-γ)6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of Tumor Necrosis Factor Alpha (TNF-α)6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Number of bridged cortices in conventional X-ray6 months after tibia fracture surgery
Number of bridged cortices in computed tomography scan6 months after tibia fracture surgery
Bone Stiffness by a CT-based finite element method6 months after tibia fracture surgeryFinite element method will be used to simulate the mechanical behavior (linear-elastic range) of the tibia and predict bending stiffness under a 3-point bending test
Functional index in trauma (FIX-IT) - Score6 months after tibia fracture surgeryAssess weight-bearing and pain in patients with lower extremity fractures eight-bearing and pain in patients with lower extremity fractures. The score rank from 0 to 12 points in 2 domains: the ability to bear weight (maximum 6 points) and pain at the fracture site (maximum 6 points). The scores in both domains, which are weighted equally, are summed to obtain the final total score; (maximum 12 points indicates the highest level of function).
Loading of the injured extremity6 months after tibia fracture surgeryThe time period with no, sole contact, partial or full load on the injured extremity.
Lower Extremity Functional Scale (LEFS) - Score6 months after tibia fracture surgeryThe Lower Extremity Functional Scale (LEFS) is a questionnaire (20 questions) about a person's ability to perform everyday tasks. The LEFS will be used to evaluate the functional impairment of a patient with a disorder of lower extremity. The score rank from 0 to 80 points. The maximum score (80 point) indicates no functional limitations.
Number of complications associated with the healing process6 months after tibia fracture surgery
Number of hospital stay and incapacity to work [days]6 months after tibia fracture surgery
Physicians Global Assessment to measure quality of life (PROMIS GH10 v 1.2) - Score6 months after tibia fracture surgeryThe Global Health Patient-Reported Outcomes Measurement Information System (PROMIS- 10) scale is a ten-item patient reported measure of physical, mental and social health. Two summary scores are calculated from the results of the questions: a global physical health score and a global mental health score. These scores are then normalized to the general population using the T-score. The score ranges from 0 to 20 points. 0 points represent the most severe physical and/or mental impairment of the patient, while 20 points represent the best possible health status.
Visual Analog Score for pain (VAS) - Score6 months after tibia fracture surgeryVisual Analog Scale for Pain (VAS) provide an estimate of patients' pain intensity. Scale from cero (no pain) to 10 (extreme pain).
Concentration of Alkaline Phosphatase (BAP)6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)Marker osteoblast activity
Concentration of Osteoprogesterin6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)Decoy receptor RANKL - inhibit osteoclast differentiation

Other

MeasureTime frameDescription
Concentration of Leucocytes6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of Erythrocytes6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of Hemoglobin6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of Thrombocytes6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Mean corpuscular volume6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Hematocrit levels6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Mean corpuscular hemoglobin levels6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Corpuscular hemoglobin concentration6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Protein c reactive levels6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Alcohol consume6 months after tibia surgeryCompensation cigarette abstinence with alcohol
Questionnaire on Smoking Urges (QSU-G) - Score6 months after tibia surgery
Smoking behaviour6 months after tibia surgeryNumber of cigarettes or THS heets consume
Nicotine withdrawal syndrome assessment - Checklist6 months after tibia surgery
Concentration of Soluble intercellular adhesion molecule-1 (sICAM-1)6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
Concentration of High densitiy lipoprotein cholesterol levels (HDL)6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)

Countries

Germany

Contacts

Primary ContactAndreas K. Nüssler, Prof. Dr.
andreas.nuessler@med.uni-tuebingen.de+49070716061065
Backup ContactBenedikt J. Braun, PD. Dr.
bbraun@bgu-tuebingen.de+49070716063017

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026